DHR
Danaher Corporation
NYSE: DHR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$178.95
+0.08% today
Updated 2026-04-29
Market cap
$126.55B
P/E ratio
34.58
P/S ratio
5.11x
EPS (TTM)
$5.17
Dividend yield
0.76%
52W range
$175 – $242
Volume
4.3M
WallStSmart proprietary scores
58
out of 100
Grade: C+
Hold
Investment rating
4.0
Growth
C6.3
Quality
B6.0
Profitability
B4.0
Valuation
C4/9
Piotroski F-Score
Moderate
2.4
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$250.14
+39.78%
12-Month target
$151.39
-15.40%
Intrinsic (DCF)
$136.44
Margin of safety
-31.16%
4 Strong Buy18 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $1.08B — positive
Risks
- 31.16% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $26.64B | $23.89B | $23.88B | $24.57B | $24.78B | $26.9B |
| Net income | $7.21B | $4.74B | $3.90B | $3.61B | $1.03B | — |
| EPS | — | — | — | — | $5.17 | $8.49 |
| Free cash flow | $7.37B | $5.78B | $5.30B | $5.26B | $1.08B | — |
| Profit margin | 27.06% | 19.85% | 16.33% | 14.71% | 14.90% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-01 | SAWYER, MONTGOMERY JULIE A | Buy | 16,681 | — |
| 2026-03-01 | SAWYER, MONTGOMERY JULIE A | Buy | 6,172 | — |
| 2026-03-01 | SAWYER, MONTGOMERY JULIE A | Sale | 1,080 | $210.64 |
Peer comparison
Smart narrative
Danaher Corporation trades at $178.95. representing a P/E of 34.58x trailing earnings. Our Smart Value Score of 58/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.36, it sits in the grey zone. TTM revenue stands at $24.78B. with profit margins at 14.90%. Our DCF model estimates intrinsic value at $136.44.
Frequently asked questions
What is Danaher Corporation's stock price?
Danaher Corporation (DHR) trades at $178.95.
Is Danaher Corporation overvalued?
Smart Value Score 58/100 (Grade C+, Hold). DCF value $136.44.
What is the price target of Danaher Corporation (DHR)?
The analyst target price is $250.14, representing +39.8% upside from the current price of $178.95.
What is the intrinsic value of Danaher Corporation (DHR)?
Based on our DCF model, intrinsic value is $136.44, a -31.2% margin of safety versus $178.95.
What is the future stock price of DHR by 2030?
Our research-backed model estimates Danaher Corporation could reach $592.47 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Danaher Corporation's revenue?
TTM revenue is $24.78B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.36 — grey zone.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio5.11x
ROE7.08%
Beta0.99
50D MA$194.30
200D MA$208.86
Shares out0.71B
Float0.63B
Short ratio—
Avg volume4.3M
Performance
1 week+0.87%
1 month-6.28%
3 months-18.32%
YTD-21.89%
1 year—
3 years—
5 years—